Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012
Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002
Relationship between Candida strains colonization and MMP-9 and TIMP-1 induced sputum concentration in chronic obstructive pulmonary disease‘s (COPD) patients and healthy control group Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017
P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
C-reactive protein levels in COPD according to clinical parameters, smoking behavior and pulmonary hypertension Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012
Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005